Teva Pharmaceutical Industries Limited Q2 adjusted earnings Beat Estimates

(RTTNews) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: -$241 million in Q2 vs. -$6035 million in the same period last year. -EPS: -$0.24 in Q2 vs. -$5.94 in the same period last year. -Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $794 million or $0.78 per share for the period. -Analysts projected $0.64 per share -Revenue: $4.70 billion in Q2 vs. $5.72 billion in the same period last year.

-Guidance: Full year EPS guidance: $2.55 - $2.80 Full year revenue guidance: $18.5 - $19.0 Bln